Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
39.3%
% of WDNA's 91 holdings also in XBI
26.9%
% of XBI's 131 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.9% | 1.2% | 1.2% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 1.1% | 1.1% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% | 1.1% | 1.1% |
|
BLUEPRINT MEDICINES CORP. | 2.2% | 1.1% | 1.1% |
|
AMGEN INC | 1.1% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XBI
|
IOVANCE BIOTHERAPEUTICS INC | 3.0% |
|
FATE THERAPEUTICS INC | 2.5% |
|
TWIST BIOSCIENCE CORP. | 2.4% |
 |
NOVOZYMES A/S-B SHARES | 2.4% |
|
ELI LILLY & CO | 1.9% |
|
CARIBOU BIOSCIENCES, INC. | 1.4% |
|
CATALENT INC | 1.3% |
|
DANAHER CORP | 1.3% |
|
REPLIGEN CORP | 1.2% |
 |
NOVARTIS AG | 1.2% |
WDNA Underweight Relative to XBI
|
CRINETICS PHARMACEUTICALS INC | -1.2% |
|
CYTOKINETICS INC | -1.2% |
 |
ROIVANT SCIENCES LTD. | -1.2% |
|
VIKING THERAPEUTICS, INC. | -1.1% |
|
KRYSTAL BIOTECH, INC. | -1.1% |
|
EXELIXIS INC | -1.1% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -1.1% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.1% |
|
NEUROCRINE BIOSCIENCES INC | -1.1% |
|
INSMED INC | -1.1% |